Management of Asymptomatic Severe Hyponatremia (Serum Sodium ≈ 105 mEq/L)

Diagnostic Workup

• Assess medication exposure (e.g., diuretics, antidepressants, anticonvulsants, laxatives, SGLT2 inhibitors, immune‑checkpoint inhibitors) to identify drug‑induced hyponatremia. 2
• Perform infection screening, including appropriate cultures and diagnostic paracentesis when ascites is present, to rule out infectious contributors. 2

Initial Conservative Management (Asymptomatic Patients)

• Restrict oral fluid intake to ≈ 1 L per day as first‑line therapy for severe hyponatremia in asymptomatic individuals. 1
• Provide oral sodium chloride (e.g., 100 mEq three times daily) to promote free‑water excretion when needed. 1
• Encourage a high‑protein diet to increase urinary solute load and aid water excretion. 1
• Discontinue or reduce potentially hyponatremic agents such as diuretics and laxatives. 2

Safe Correction Rate Limits

• Do not exceed a total rise of 8–10 mEq/L in serum sodium during the first 24 hours to avoid osmotic demyelination syndrome. 1
• Target a serum sodium of ≈ 125–131 mEq/L rather than full normalization when using conservative measures. 3

Criteria for Escalating Care

• Transfer to a higher‑level care unit and increase monitoring frequency if any of the following occur:
  
  • Development of neurological symptoms (confusion, seizures, altered mental status, nausea, vomiting). 2
  • Serum sodium remains < 120 mEq/L despite adequate fluid restriction and oral sodium supplementation. 2

Second‑Line Therapies (If Fluid Restriction Fails)

• For euvolemic hyponatremia (e.g., SIADH) unresponsive to fluid restriction, oral urea (≈ 40 g every 8 hours) is an effective and safe second‑line option. 3

Special Considerations in Patients with Cirrhosis

• Apply combined sodium and water restriction (≈ 1–1.5 L fluid per day) in hypervolemic hyponatremia associated with ascites. 2
• Hold or reduce diuretics until serum sodium rises above ≈ 125 mEq/L. 2
• Correct concurrent hypokalemia, especially when hepatic encephalopathy is present. 2
• Consider intravenous albumin or midodrine only in the setting of hypotension (systolic < 90 mmHg). 2
• Suspend non‑selective beta‑blockers if blood pressure is low. 2

Critical Pitfalls to Avoid

• Do not administer 3 % hypertonic saline to asymptomatic patients, regardless of the severity of hyponatremia. 1
• Do not impose fluid restriction in hypovolemic individuals; volume status must be assessed first. 1
• Do not pursue rapid normalization of serum sodium in asymptomatic cases, as the risk of osmotic demyelination outweighs potential benefits. 1

Monitoring Protocol

• Check serum sodium at least once daily while conservative management is in place. 1
• Increase monitoring frequency to every 4–6 hours when active pharmacologic therapy (e.g., oral urea) is initiated. 3
• Continue daily checks until serum sodium stabilizes above ≈ 131 mEq/L. 1